uMotif to Showcase Modern eConsent and eCOA Platform to Support the Pivotal Patient-Site Relationship in Clinical Trials at Fall 2025 Life Sciences Conferences
Summary
uMotif will showcase its eConsent and eCOA platform at multiple life sciences conferences in late 2025. The company will send senior executives to speak about improving patient-site relationships, reducing site burden, and using AI in clinical research workflows. Its platform supports clinical trials and real-world studies with cloud hosting in the US, Europe, and China and compliance for GCP, 21 CFR Part 11, and GDPR. The announcement also invites attendees to arrange meetings with uMotif executives at the events.
Classifications
industries
HealthTech
applications
Web and Content Management
AskAI Classifications
Labels
Clinical Trial Software
Healthcare SaaS
Data Capture Software
Linked Companies
uMotif
$1M to $5M